Latest filing published 18 Feb 2026 for Solid Biosciences Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ilan Ganot is a declared insider of Solid Biosciences Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 10 February 2022 to 13 February 2026, the count stands at 18 filings.
The open-market record consists of 3 sales worth €51k, with no purchase. The rest of the record consists of 15 option exercises. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 18 February 2026, reports an option exercise in Solid Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations